Skip to Main Content
An official website of the United States government

Approved Projects

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Filter results of approved projects table below

Showing Most Recent
1-20 of 2661
Approved Projects
Name Principal Investigator Institution Study Date Approved Project ID
Validation of a bladder cancer risk model with lifestyle and environmental risk factors and polygenic risk score in two prospective cohorts. (PLCO-1972 continued) Parichoy Pal Choudhury American Cancer Society PLCO Mar 16, 2026 PLCO-2033
Utilizing serial screening data to estimate dwell time of cancers and colorectal adenomas and develop new cancer stage progression models Joachim Worthington The University of Sydney PLCO Mar 16, 2026 PLCO-2032
Lung cancer incidence following negative biopsy Paul Pinsky NCI NLST Mar 16, 2026 NLST-1498
The "MetaboMap" project Anindya Roy University of Maryland Baltimore County PLCO Mar 4, 2026 PLCO-2030
Continuation of Novel Dietary Index for Gut Microbiota and Associations with Colorectal Cancer and Breast Cancer Risk PLCO-730 Susan Steck University of South Carolina PLCO Mar 4, 2026 PLCO-2029
Development of ML-Based Early Cancer Confirmation and Stage Classification Models for Ovarian and Colorectal Cancer Using PLCO Trial Data Dr. Mehdi Hasan Chowdhury Chittagong University of Engineering & Technology (CUET) PLCO Mar 4, 2026 PLCO-2026
Effect of Stage and Grade on Colorectal Cancer Mortality Paul Pinsky National Institutes of Health PLCO Feb 26, 2026 PLCO-2028
Early Risk Prediction of Ovarian Cancer Using Multimodal Clinical and Biomarker Data Vanshika Sharma Chandigarh University PLCO Feb 23, 2026 PLCO-2020
A Risk-Stratified Decision Support Framework for Prostate Cancer Screening Using the PLCO Trial Dataset Priya Dubey Tokyo International University PLCO Feb 23, 2026 PLCO-2014
Validation of CA-125 Kinetic Models for Early Ovarian Cancer Detection Using Machine Learning Fahad Kiani CrisPRO.ai PLCO Feb 23, 2026 PLCO-2010
Standardization of Imaging Interpretation for Early Lung Cancer Detection, Intelligent Learning Platforms, and Public Education Outreach Dr. Yeun-Chung Chang The Radiological Society of the Republic of China (RSROC) NLST Feb 20, 2026 NLST-1493
Plasma proteomics markers for risk prediction of incident lung cancer Charles Swanton Francis Crick Institute PLCO Feb 19, 2026 2025-0069
DNA methylation and dietary sodium intake Jeong Yun (John) Yang Columbia University Irving Medical Center PLCO Feb 17, 2026 PLCO-2023
Dietary Advanced Glycation End-Products (dAGE) and Prostate Cancer Susan Steck University of South Carolina PLCO Feb 13, 2026 PLCO-2021
Computational Prediction of Gene Expression and Clinical Outcomes from Digital Pathology Images Mingyao Li University of Pennsylvania PLCO Feb 13, 2026 PLCOI-2022
Validation of a Morphology-Based Risk Taxonomy (Favorable, Borderline, Unfavorable Histology) for Prostate Cancer Using PLCO Trial Data Enrico Munari University Hospital Trust Verona PLCO Feb 4, 2026 PLCOI-2019
Bone Marrow Extracellular Matrix Gene Expression Analysis for Cancer Prognosis and Bone Metastasis Prediction: An 82-Gene Panel Study Using PLCO Trial Data Shelly Peyton Trustees of Tufts College PLCO Feb 4, 2026 PLCO-2011
Causal predictive modeling of survival of Breast cancer: A comparative study with machine learning, traditional survival modeling methods, and causal survival models Hansapani Rodrigo University of Texas Rio Grande Valley PLCO Feb 4, 2026 PLCO-2015
Calibration of a microsimulation model of lung cancer natural history in Australia Marianne Weber The University of Sydney NLST Feb 4, 2026 NLST-1495
Epstein-Barr virus-associated neo-antigens in advanced prostate cancer Denong Wang SRI International PLCO Feb 2, 2026 2025-0062